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Dear Editor,
Among severe neurological conditions, epilepsy is the most 
prevalent, occurring in 0.5% of the general population, with a higher 
prevalence among children and adolescents. Several studies point 
that chronic diseases produce higher susceptibility to psychiatric 
morbidity when compared to control groups. The World Health 
Organization developed an instrument to assess the quality of life 
in the framework of a collaborative multicentre  project (WHOQOL 
Group), which has been widely applied in Brazil in its Portuguese 
version.1 The Quality of life (QOL) approach has been considered 
one of the best alternatives for the psychic evaluation of children 
with chronic conditions. Unfortunately, we still cannot describe 
such development of instruments concerning the evaluation of 
the quality of life evaluation among children and adolescents. We 
present a study of QOL in children and adolescents with epilepsy 
(CAWE) using a self-applying questionnaire and comparing its 
performance to questionnaires applied to parents.
We evaluated 28 outpatients with childhood epilepsy diagnosis 
and follow-up, aged 4 to 12 years and 11 months, and 28 matched 
healthy schoolchildren, and we also interviewed the parents of both 
groups. The Autoquestionnaire Qualité de Vie Enfant Imagé (AUQEI), 
validated for the local population,2 was applied to children and 
adolescents. We also applied the Children’s Global Assessment Scale 
(CGAS)3 and the Vineland Adaptive Behavior Scale (VINELAND),4 the 
Table 1 - Groups’ characteristics and scales descriptives 
Epileptic Control 
n (%) 28 (100) 28 (100) 
(T test)
Sex
Male (5) 14 (50) 12 (42.86) 
Female (%) 14 (50) 16 (57.14) 
Age (years)
< 8 (%) 11 (39.29) 16 (57.14) 
8-12 (%) 17 (60.71) 12 (42.86) 
(to 1.83) 
CGAS Score: m (sd) 86.32 (17.35) 91.11 (6.21) 
(to 1.35) 
Total Vineland Score: m (sd) 69.71 (17.76) 94.75 (10.64) 
(to 6.28) 
Communication Vineland Score: m (sd) 75.64 (18.89) 100.79 (16.97) 
(to 5.15) 
Daily Activities Vineland Score: m (sd) 72.39 (24.31) 94.79 (8.92) 
(to 4.79) 
Social Skills Vineland Score: m (sd) 74.89 (13.80) 93.61 (13.28) 
(to 5.08) 
AUQEI Score: m (sd) 53.36 (5.72) 58.43 (6.69) 
(to 2.99) 
n: number of cases; CGAS: Children’s Global Assessment Scale; m: mean;
sd: standard deviation; AUQEI: Autoquestionnaire Qualité de Vie Enfant 
Imagé
T test: T independent test, < 0.05 
last one composed by a total score and three subordinate domains: 
communication, daily living skills and socialization. CGAS and 
VINELAND were applied to parents. T independent test was used to 
analyze the data. The significance level adopted was of 5%.
Results are presented in Table 1. No significant differences were 
observed between age groups (to 1.83) and as to CGAS scores (to
1.35). Significant differences were observed as to Vineland total 
scores. CAWE had worse performance than controls (to 6.28), as 
well as regarding to communication (to 5.15), daily living skills 
(to 4.79) and socialization (to 5.08) domains results. Significant 
differences were observed for AUQEI results (to 2.99). The CAWE 
group had worse results than matched controls.
The majority of studies investigating the impact of epilepsy 
on QOL of children and adolescents have used proxy opinions, 
with clinician and/or parent reports. This study highlights the 
need for research investigating QOL from the direct perspective of 
children and considering issues in the context of a developmental 
perspective. For this purpose, in this study we used a self-reporting 
questionnaire. CAWE clearly demonstrated inferior performance in 
regard to self perception of QOL and to the development of an 
adaptive behavior, even though these went unrecognized by their 
parents, as shown by CGAS.
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leukemia and juvenile rheumatoid arthritis, performed worse in
adaptive behavior development.5 In this context, CAWE are no 
exception. With regardto global functioning, obtained from CGAS, 
there were no significant statistical differences in our study, 
demonstrating the absence of a higher incidence of complaints of 
this nature arising from parents, in relation to their chronic disease.
Adequate instruments should be necessarily developed to assess 
perceptions of disease and treatment from  chronic pediatric 
patients themselves, aiming to increase attention given to this 
growing and needing population in terms of mental health.5
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